Published in Inflamm Bowel Dis on October 01, 2013
Fecal microbiota transplantation as therapy for inflammatory bowel disease: a systematic review and meta-analysis. J Crohns Colitis (2014) 1.96
In vivo imaging and tracking of host-microbiota interactions via metabolic labeling of gut anaerobic bacteria. Nat Med (2015) 1.62
Inflammatory bowel disease as a model for translating the microbiome. Immunity (2014) 1.39
Bacteroides fragilis subverts mucosal biology: from symbiont to colon carcinogenesis. J Clin Invest (2014) 1.33
Fecal Microbiota Transplantation as a Novel Therapy for Ulcerative Colitis: A Systematic Review and Meta-Analysis. Medicine (Baltimore) (2016) 0.79
Intestinal upregulation of melanin-concentrating hormone in TNBS-induced enterocolitis in adult zebrafish. PLoS One (2013) 0.78
T Lymphocyte Dynamics in Inflammatory Bowel Diseases: Role of the Microbiome. Biomed Res Int (2015) 0.75
Intestinal microbiota, fecal microbiota transplantation, and inflammatory bowel disease. Gut Microbes (2017) 0.75
The Toxin-Producing Pathobiont Klebsiella oxytoca Is Not Associated with Flares of Inflammatory Bowel Diseases. Dig Dis Sci (2015) 0.75
An immunomodulatory molecule of symbiotic bacteria directs maturation of the host immune system. Cell (2005) 15.46
Genome analysis of multiple pathogenic isolates of Streptococcus agalactiae: implications for the microbial "pan-genome". Proc Natl Acad Sci U S A (2005) 14.59
A microbial symbiosis factor prevents intestinal inflammatory disease. Nature (2008) 13.15
Gut immune maturation depends on colonization with a host-specific microbiota. Cell (2012) 5.91
Microbial exposure during early life has persistent effects on natural killer T cell function. Science (2012) 5.90
Complete genome sequence and comparative genomic analysis of an emerging human pathogen, serotype V Streptococcus agalactiae. Proc Natl Acad Sci U S A (2002) 5.28
Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science (2005) 3.83
Polysaccharide processing and presentation by the MHCII pathway. Cell (2004) 2.88
CD4+ T cells mediate abscess formation in intra-abdominal sepsis by an IL-17-dependent mechanism. J Immunol (2003) 2.79
A mechanism for glycoconjugate vaccine activation of the adaptive immune system and its implications for vaccine design. Nat Med (2011) 2.78
A bacterial carbohydrate links innate and adaptive responses through Toll-like receptor 2. J Exp Med (2006) 2.41
The love-hate relationship between bacterial polysaccharides and the host immune system. Nat Rev Immunol (2006) 2.31
TLR-independent type I interferon induction in response to an extracellular bacterial pathogen via intracellular recognition of its DNA. Cell Host Microbe (2008) 1.98
Central nervous system demyelinating disease protection by the human commensal Bacteroides fragilis depends on polysaccharide A expression. J Immunol (2010) 1.92
Regulation of surface architecture by symbiotic bacteria mediates host colonization. Proc Natl Acad Sci U S A (2008) 1.79
A mechanism for neurodegeneration induced by group B streptococci through activation of the TLR2/MyD88 pathway in microglia. J Immunol (2006) 1.76
Microbial colonization drives expansion of IL-1 receptor 1-expressing and IL-17-producing gamma/delta T cells. Cell Host Microbe (2010) 1.71
Cellular activation, phagocytosis, and bactericidal activity against group B streptococcus involve parallel myeloid differentiation factor 88-dependent and independent signaling pathways. J Immunol (2002) 1.63
Bacterial glycans: key mediators of diverse host immune responses. Cell (2006) 1.57
IFN-gamma regulated chemokine production determines the outcome of Staphylococcus aureus infection. J Immunol (2008) 1.53
Zwitterionic polysaccharides stimulate T cells by MHC class II-dependent interactions. J Immunol (2002) 1.50
Regulation of virulence by a two-component system in group B streptococcus. J Bacteriol (2005) 1.46
How bacterial carbohydrates influence the adaptive immune system. Annu Rev Immunol (2010) 1.45
Glycoconjugate vaccines to prevent group B streptococcal infections. Expert Opin Biol Ther (2003) 1.42
Role of lipoteichoic acid in the phagocyte response to group B streptococcus. J Immunol (2005) 1.35
A defined O-antigen polysaccharide mutant of Francisella tularensis live vaccine strain has attenuated virulence while retaining its protective capacity. Infect Immun (2007) 1.27
Beneficial effects of Bacteroides fragilis polysaccharides on the immune system. Front Biosci (Landmark Ed) (2010) 1.27
The yin yang of bacterial polysaccharides: lessons learned from B. fragilis PSA. Immunol Rev (2012) 1.23
Zwitterionic polysaccharides stimulate T cells with no preferential V beta usage and promote anergy, resulting in protection against experimental abscess formation. J Immunol (2004) 1.21
Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens. Cell Microbiol (2005) 1.18
Small molecule control of virulence gene expression in Francisella tularensis. PLoS Pathog (2009) 1.17
Type I Streptococcus pneumoniae carbohydrate utilizes a nitric oxide and MHC II-dependent pathway for antigen presentation. Immunology (2009) 1.17
The starting lineup: key microbial players in intestinal immunity and homeostasis. Front Microbiol (2011) 1.16
Impaired antibody response to group B streptococcal type III capsular polysaccharide in C3- and complement receptor 2-deficient mice. J Immunol (2003) 1.14
Characteristics of carbohydrate antigen binding to the presentation protein HLA-DR. Glycobiology (2008) 1.14
CD4+ T cells regulate surgical and postinfectious adhesion formation. J Exp Med (2002) 1.11
A unique structural pattern shared by T-cell-activating and abscess-regulating zwitterionic polysaccharides. Biochemistry (2002) 1.11
Membrane sphingolipids as essential molecular signals for Bacteroides survival in the intestine. Proc Natl Acad Sci U S A (2010) 1.09
Role of T cells in abscess formation. Curr Opin Microbiol (2002) 1.08
Type III group B streptococcal polysaccharide induces antibodies that cross-react with Streptococcus pneumoniae type 14. Infect Immun (2002) 1.08
Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. J Infect Dis (2004) 1.06
Cellular and humoral immunity are synergistic in protection against types A and B Francisella tularensis. Vaccine (2008) 1.04
Safety and immunogenicity of a bivalent group B streptococcal conjugate vaccine for serotypes II and III. J Infect Dis (2003) 1.02
Effect of B7-2 and CD40 signals from activated antigen-presenting cells on the ability of zwitterionic polysaccharides to induce T-Cell stimulation. Infect Immun (2005) 1.02
Oxidative depolymerization of polysaccharides by reactive oxygen/nitrogen species. Glycobiology (2010) 0.98
Characterization of the O-antigen polymerase (Wzy) of Francisella tularensis. J Biol Chem (2010) 0.98
Deciphering the tête-à-tête between the microbiota and the immune system. J Clin Invest (2014) 0.97
Microbial carbohydrate depolymerization by antigen-presenting cells: deamination prior to presentation by the MHCII pathway. Proc Natl Acad Sci U S A (2008) 0.97
Systemic Toll-like receptor ligands modify B-cell responses in human inflammatory bowel disease. Inflamm Bowel Dis (2010) 0.95
Resident commensals shaping immunity. Curr Opin Immunol (2013) 0.95
Carbohydrates and T cells: a sweet twosome. Semin Immunol (2013) 0.95
Symbiotic commensal bacteria direct maturation of the host immune system. Curr Opin Gastroenterol (2008) 0.94
Quantitative determination of immunoglobulin G specific for group B streptococcal beta C protein in human maternal serum. J Infect Dis (2002) 0.92
Maternal antibody at delivery protects neonates from early onset group B streptococcal disease. J Infect Dis (2013) 0.92
Deficiency of mannose-binding lectin greatly increases antibody response in a mouse model of vaccination. Clin Immunol (2008) 0.92
Bacteroides fragilis polysaccharide A is necessary and sufficient for acute activation of intestinal sensory neurons. Nat Commun (2013) 0.91
Modulation of surgical fibrosis by microbial zwitterionic polysaccharides. Proc Natl Acad Sci U S A (2005) 0.90
Biological chemistry of immunomodulation by zwitterionic polysaccharides. Carbohydr Res (2003) 0.90
Coming of age: carbohydrates and immunity. Eur J Immunol (2005) 0.90
Isolation of carbohydrate-specific CD4(+) T cell clones from mice after stimulation by two model glycoconjugate vaccines. Nat Protoc (2012) 0.90
3-Deoxy-D-manno-octulosonic acid (Kdo) hydrolase identified in Francisella tularensis, Helicobacter pylori, and Legionella pneumophila. J Biol Chem (2010) 0.89
Group A streptococcus epidemiology and vaccine implications. Clin Infect Dis (2007) 0.89
A commensal symbiotic factor derived from Bacteroides fragilis promotes human CD39(+)Foxp3(+) T cells and Treg function. Gut Microbes (2015) 0.89
Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine. J Infect Dis (2011) 0.88
Conjugate vaccines against group B Streptococcus types IV and VII. J Infect Dis (2002) 0.87
Bacteroides fragilis-stimulated interleukin-10 contains expanding disease. J Infect Dis (2011) 0.86
Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity. MBio (2013) 0.86
Regulation of T cells by gut commensal microbiota. Curr Opin Rheumatol (2011) 0.85
Rational chemical design of the carbohydrate in a glycoconjugate vaccine enhances IgM-to-IgG switching. Proc Natl Acad Sci U S A (2008) 0.84
Construction of designer glycoconjugate vaccines with size-specific oligosaccharide antigens and site-controlled coupling. Vaccine (2003) 0.84
A maternal vaccine against group B Streptococcus: past, present, and future. Vaccine (2013) 0.84
Orientations of the Bacteroides fragilis capsular polysaccharide biosynthesis locus promoters during symbiosis and infection. J Bacteriol (2010) 0.84
Induction of cross-reactive antibodies by immunization of healthy adults with types Ia and Ib group B streptococcal polysaccharide-tetanus toxoid conjugate vaccines. J Infect Dis (2002) 0.84
Commentary: Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J Infect Dis 1977; 136:701. J Infect Dis (2004) 0.81
The atypical lipopolysaccharide of Francisella. Carbohydr Res (2013) 0.81
Sensitivity of Francisella tularensis to ultrapure water and deoxycholate: implications for bacterial intracellular growth assay in macrophages. J Microbiol Methods (2011) 0.80
Role of murine intestinal interleukin-1 receptor 1-expressing lymphoid tissue inducer-like cells in Salmonella infection. PLoS One (2013) 0.80
Novel tools for modulating immune responses in the host-polysaccharides from the capsule of commensal bacteria. Adv Immunol (2010) 0.78
Anchors away: contribution of a glycolipid anchor to bacterial invasion of host cells. J Clin Invest (2005) 0.77
Testosterone: more than having the guts to win the Tour de France. Immunity (2013) 0.76
Traffic control at the "Gut-GALT crossroads". Cell Res (2013) 0.75